0001127602-21-023108.txt : 20210804 0001127602-21-023108.hdr.sgml : 20210804 20210804182806 ACCESSION NUMBER: 0001127602-21-023108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210802 FILED AS OF DATE: 20210804 DATE AS OF CHANGE: 20210804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wall Brett A. CENTRAL INDEX KEY: 0001473812 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 211145578 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PARKWAY STREET 2: LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-08-02 0001613103 Medtronic plc MDT 0001473812 Wall Brett A. 710 MEDTRONIC PARKWAY LC300 MINNEAPOLIS MN 55432 1 EVP & Pres Neuroscience Ordinary Shares 2021-08-02 4 F 0 1482 131.31 D 20062 D Ordinary Shares 2021-08-02 4 A 0 5333 0 A 25395 D Stock Option (Right to Buy) 131.26 2021-08-02 4 A 0 45565 0 A 2022-08-02 2031-08-02 Ordinary Shares 45565 45565 D Stock Option (Right to Buy) 131.26 2021-08-02 4 A 0 1085 0 A 2022-08-02 2031-08-02 Ordinary Shares 1085 1085 D Performance Share Units 2021-08-02 4 A 0 13333 0 A Performance Share Units 13333 13333 D This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment. This balance increased by 83 shares due to exempt transactions such as dividend reinvestment. The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Each performance share unit represents a contingent right to receive one share of Medtronic common stock. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 13,333 shares will be issued. The actual number of shares to be issued could range from a low of 2,667 shares at minimum performance to a high of 26,666 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Vests on August 2, 2024. /s/ Thomas L. Osteraas, attorney-in-fact 2021-08-04